JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 42:831-838, doi:10.1016/S0735-1097(03)00833-7
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vivekananthan, D. P.
Right arrow Articles by Lauer, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vivekananthan, D. P.
Right arrow Articles by Lauer, M. S.

CLINICAL RESEARCH

Heart rate recovery after exercise is apredictor of mortality, independent of the angiographic severity of coronary disease

Deepak P. Vivekananthan, MD*, Eugene H. Blackstone, MD, FACC{dagger}{ddagger}, Claire E. Pothier, MA* and Michael S. Lauer, MD, FACC, FAHA*,*

* Departments of Cardiovascular Medicine, Cleveland, Ohio, USA
{dagger} Cardiothoracic Surgery, Cleveland, Ohio, USA
{ddagger} Epidemiology and Biostatistics, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Manuscript received October 9, 2002; revised manuscript received January 1, 2003, accepted January 11, 2003.

* Reprint requests and correspondence: Dr. Michael S. Lauer, Desk F25, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.
Lauerm{at}ccf.org


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
OBJECTIVES: We sought to determine whether abnormal heart rate recovery predicts mortality independent of the angiographic severity of coronary disease.

BACKGROUND: An attenuated decrease in heart rate after exercise, or heart rate recovery (HRR), has been shown to predict mortality. There are few data on its prognostic significance once the angiographic severity of coronary artery disease (CAD) is ascertained.

METHODS: For six years we followed 2,935 consecutive patients who underwent symptom-limited exercise testing for suspected CAD and then had a coronary angiogram within 90 days. The HRR was abnormal if ≤12 beats/min during the first minute after exercise, except among patients undergoing stress echocardiography, in whom the cutoff was ≤18 beats/min. Angiographic CAD was considered severe if the Duke CAD Prognostic Severity Index was ≥42 (on a scale of 0 to 100), which corresponds to a level of CAD where revascularization is associated with better long-term survival.

RESULTS: Severe CAD was present in 421 patients (14%), whereas abnormal HRR was noted in 838 patients (29%). There were 336 deaths (11%). Mortality was predicted by abnormal HRR (hazard ratio [HR] 2.5, 95% confidence interval [CI] 2.0 to 3.1; p < 0.0001) and by severe CAD (HR 2.0, 95% CI 1.6 to 2.6; p < 0.0001); both variables provided additive prognostic information. After adjusting for age, gender, standard risk factors, medications, exercise capacity, and left ventricular function, abnormal HRR remained predictive of death (adjusted HR 1.6, 95% CI 1.2 to 2.0; p < 0.0001); severe CAD was also predictive (adjusted HR 1.4, 95% CI 1.1 to 1.9; p = 0.008).

CONCLUSIONS: Even after taking into account the angiographic severity of CAD, left ventricular function, and exercise capacity, HRR is independently predictive of mortality.

Abbreviations and Acronyms
  CAD
  coronary artery disease
  CI
  confidence interval
  ESRD
  end-stage renal disease
  HR
  hazard ratio
  HRR
  heart rate recovery
  MET
  metabolic equivalent
  PVD
  peripheral vascular disease


Impaired heart rate recovery (HRR) after exercise predicts mortality (1–3), even after accounting for ischemia (3,4), chronotropic incompetence (1–3,5), and the Duke treadmill score (5). There are few data on its prognostic significance once the angiographic severity of coronary artery disease (CAD) is ascertained. In a recent study of male veterans, HRR predicted death, independent of angiographic results, but there was no correlation between HRR and the angiographic severity of disease (6). We examined the association between abnormal HRR and mortality among men and women referred for exercise stress testing and coronary angiography. All-cause mortality was chosen as an unbiased and objective end point (7).


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Patient population.   The cohort was derived from consecutive adults referred for symptom-limited treadmill testing at the Cleveland Clinic Foundation between September 1990 and March 1998. All patients were undergoing their first treadmill test at our institution. Patients were eligible if they underwent coronary angiography within 90 days. Exclusion criteria included a history of heart failure, valvular disease, pre-excitation, congenital disease, coronary interventions or surgery, pacemaker placement, use of digoxin, atrial fibrillation, and absence of a recorded U.S. Social Security number. The Cleveland Clinic Foundation's Institutional Review Board approved the performance of research on this clinical data base.

Of the 2,935 patients who met these criteria, 1,384 (47%) have been included in previous publications (1,4,5). However, we have not published any data on their angiographic characteristics' relation to HRR or whether HRR predicts death in these patients once angiographic data are known.

Clinical data.   A structured interview and chart review were conducted before each treadmill test regarding symptoms, medications, risk factors, cardiac history, and noncardiac diagnoses (8). Resting hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or treatment with antihypertensive medication (9). Diagnoses of diabetes mellitus and chronic lung disease were determined on the basis of chart review, patient interviews, and medication use. Hypercholesterolemia was defined as a recent total cholesterol value ≥200 mg/dl or use of a lipid-lowering drug. A history of coronary disease was considered present when there were documented hospitalizations for myocardial infarction or unstable angina. All clinical data, as well as directly measured height and weight, were prospectively recorded on-line.

Exercise testing.   Symptom-limited exercise testing procedures in our laboratory have been described (10–13). Each patient underwent testing according to standard protocols. Trained exercise physiologists and/or cardiology fellows prospectively collected physiologic and hemodynamic data during testing, including symptoms, heart rate, heart rhythm, blood pressure, and estimated functional capacity in metabolic equivalents (METs; where 1 MET = 3.5 ml/kg per min of oxygen consumption). Functional capacity was defined as fair or poor for age and gender, using a previously described scheme (8). Specifically, functional capacity was considered poor among men if it was <8, 7.5, 7, 6, 5.5, 4.5, and 3.5 METs for those age <29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79, and ≥80 years, respectively. The corresponding values among women were 7.5, 7, 6, 5, 4.5, 3.5, and 2.5 METs. Among men, functional capacity was considered fair if it was not poor and it was <11, 10, 8.5, 8, 7, 5.5, and 4.5 METs for those age <29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79, and ≥80 years, respectively. The corresponding values among women were 10, 9, 8, 7, 6, 4.5, and 4 METs. We did not consider excellent functional capacity as a separate variable, because in previous work, we found that there were little differences in outcome among patients with average, good, and excellent functional capacity for age and gender (8).

A chronotropic response during exercise was defined as the percentage of heart rate reserve used at peak exercise (10). A failure to use 80% of the heart rate reserve defined chronotropic incompetence (10). ST segments were considered abnormal if there was at least 1 mm of horizontal or down-sloping ST-segment depression 80 ms after the J point in at least three consecutive beats in two contiguous leads.

Heart rate recovery.   Most patients (n = 2,426) spent at least 2 min in a cool-down period during treadmill testing at a speed of 2.4 km (1.5 miles) per hour and a grade of 2.5% after achieving peak work load. Those patients who underwent stress echocardiography (n = 509) did not have a cool-down period. The value for HRR was defined as the difference in the heart rate from peak exercise to 1 min after peak exercise.

Abnormal HRR was defined as ≤12 beats/min for standard exercise testing and ≤18 beats/min for patients who underwent stress echocardiography (3). We have previously published prognostically based justifications for these cut-off values (1,3).

Coronary angiography.   We have described the methods of the coronary angiographic procedures performed in our institution (12,14). Patients were referred for coronary angiography at the discretion of the treating physician. The referring physicians were blinded to the patients' HRR values. Cardiologists who were blinded to the patients' HRR values and to the hypothesis of this study semiquantitatively analyzed each coronary angiogram. The results were then entered into an angiographic data base.

We used the Duke CAD Prognostic Severity Index (15,16) to grade the angiographic severity of CAD. This system assigns a prognostic weight of 0 to 100 based on analyses of the Duke cardiovascular data bank. For example, a value of 0 corresponds to no significant coronary disease, whereas a score of 100 corresponds to 95% left main coronary stenosis. At least one 50% stenotic lesion is required to define the existence of any CAD. Severe CAD was prospectively defined as CAD having a prognostic weight of ≥42 by the Duke CAD Prognostic Severity Index. This value was chosen because it represents a threshold where mechanical revascularization has been previously shown to reduce mortality rates (15).

Left ventricular systolic function was semiquantitatively analyzed by contrast ventriculography or transthoracic echocardiography. We have prognostically validated visual estimates of left ventricular systolic function (3).

End points.   The primary end point was all-cause mortality during a median of six years of follow-up. Mortality was assessed by using the Social Security Death Master Files (17). In previous work, the Social Security Death Index has been shown to have a very high sensitivity (5) and specificity (18,19).

Statistical analyses.   Comparisons between patients with and without abnormal HRR were made by using the Wilcoxon rank-sum test for continuous variables and the chi-squared test for categorical variables. The association between HRR and all-cause mortality was assessed by Cox regression analyses (20). Stratified analyses of prespecified subgroups were performed according to the angiographic severity of CAD, gender, age, left ventricular systolic function, functional capacity, exercise-induced angina, ischemic ST-segment changes, or medication usage (including beta-blockers), with formal testing of interaction terms. The Cox proportional hazards assumption was confirmed by inspection of weighted Schoenfeld residuals (21).

When evaluating an association within any given data set, the apparent strength of that association may be overestimated because of idiosyncrasies of the data. To correct for this over-optimism, we used a technique called bootstrapping. Here, 250 new data sets were assembled by randomly selecting subjects from the main data set, with the possibility of selecting subjects once, never, or multiple times. Furthermore, each of these new randomly constructed data sets had only 80% of the number of subjects as the main data set, again for the purpose of minimizing the effects of idiosyncratic observations (22,23). A stepwise multivariable Cox regression analysis was performed on each of these 250 data sets, using p = 0.10 for model entry and p ≤ 0.05 for retention. Those variables that were entered into at least 50% of models were considered for a subsequent set of 1,000 fixed resamplings, which were used for estimation of hazard ratios (HRs) and confidence intervals (CIs). By fixed resamplings, we mean that the Cox models applied to each of these 1,000 bootstrap-generated data sets contained the candidate variables that were entered into 50% of the original models and that no variable selection process was used; all variables were forced in.

To assess the association between HRR, considered as a continuous variable, and mortality, we used parametric methods taking into account the possibility of changing the absolute hazard of death over time (24). These enabled us to plot estimated five-year mortality as a function of HRR, exercise capacity, angiographic coronary disease severity, and other variables. We chose to use a parametric approach for this because the use of the Cox regression model for estimation of absolute event risk has been considered by some to be problematic (25,26).

The associations of varying angiographic severities of CAD with abnormal HRR were assessed with the chi-squared test.

The statistical software package SAS version 8.2 (SAS Inc., Cary, North Carolina) was used to perform all of the analyses. Bootstrapping SAS macros were written by Eugene H. Blackstone (available on request). The parametric hazard analyses were performed using the PROC HAZRD, PROC HAZPLOT, and PROC HAZPRED functions.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Baseline, exercise, and angiographic characteristics.   Of 2,935 eligible patients, 838 (29%) had abnormal HRR. Baseline characteristics according to HRR are summarized in Table 1. Patients with abnormal HRR were older, more likely to have hypertension or diabetes, and more likely to have a history of myocardial infarction.


View this table:
[in this window]
[in a new window]
 
Table 1 Baseline Characteristics According to HRR

 
Exercise and angiographic characteristics are presented in Tables 2 and 3. Patients with abnormal HRR were more likely to have chronotropic incompetence and less likely to have abnormal ST-segment changes. Severe CAD was present in 421 patients (14%). Patients with abnormal HRR were more likely to have severe CAD (p = 0.02). However, abnormal HRR had a sensitivity of only 31% and a specificity of 76% for the detection of any CAD.


View this table:
[in this window]
[in a new window]
 
Table 2 Exercise Characteristics According to HRR

 

View this table:
[in this window]
[in a new window]
 
Table 3 Angiographic and Ventriculographic Characteristics According to HRR

 
Mortality and HRR.   During the median follow-up period of six years, there were 336 deaths (11%). Abnormal HRR predicted death (19% vs. 8%; unadjusted HR 2.5, 95% CI 2.0 to 3.1; p < 0.00001). Of the 336 patients who died, 162 (48%) had an abnormally low HRR. Other univariate predictors of mortality included older age, severe CAD, low ejection fraction, fair or poor functional capacity, a low chronotropic response index, and male gender (Table 4).


View this table:
[in this window]
[in a new window]
 
Table 4 Risk of Death in Prespecified Subgroups on Univariate Analysis

 
Abnormal HRR provided additive prognostic information to the angiographic severity of CAD (Fig. 1). There was no interaction between abnormal HRR and the angiographic severity of CAD, gender, age, left ventricular systolic function, functional capacity, exercise-induced angina, or medication usage (including beta-blockers).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1 Kaplan-Meier plot relating heart rate (HR) recovery and angiographic severity of coronary artery disease (CAD) to risk of death.

 
Multivariable Cox regression analyses.   Results of bootstrap resamplings and multivariable Cox regression analyses are shown in Table 5. Variables that entered the final model included age, use of aspirin, abnormal HRR, poor and fair functional capacity, non-test-terminating angina, current or recent smoking, end-stage renal disease (ESRD), low ejection fraction, male gender, resting tachycardia, peripheral vascular disease (PVD), severe CAD, chronotropic incompetence in the absence of a beta-blocker, insulin use, and nifedipine use. After adjustments were made for age, gender, left ventricular function, resting heart rate, chronotropic response index, exercise capacity, exercise-induced angina, ischemic ST-segment depression, the presence or absence of hypertension, diabetes, PVD, hyperlipidemia, tobacco abuse, chronic lung disease, ESRD, the use or nonuse of beta-blockers, nondihydropyridine calcium channel blockers, lipid-lowering therapy, vasodilator medications, and angiographic severity of CAD, a low value for HRR emerged as a strong predictor of death (adjusted HR 1.6, 95% CI 1.2 to 2.0; p < 0.0001).


View this table:
[in this window]
[in a new window]
 
Table 5 Results of Cox Multivariate Proportional Model*

 
Even after excluding patients with exercise-induced angina and ischemic ST-segment depression, abnormal HRR was still predictive of mortality (adjusted HR 2.1, 95% CI 1.2 to 3.5; p = 0.009). We also performed a stratified analysis according to functional capacity. There were 204 deaths in the 1,276 patients with poor or fair functional capacity. In this group, abnormal HRR strongly predicted the risk of death (HR 2.6, 95% 2.0 to 3.4; p < 0.0001). In patients with normal functional capacity, abnormal HRR still predicted death, although the association was not as strong (HR 1.7, 95% CI 1.2 to 2.4; p = 0.0067). There was no interaction between functional capacity and the risk of death associated with abnormal HRR (p = 0.07). It is important to note, though, that decreased functional capacity was itself a powerful independent predictor of death (Tables 4 and 5).

We also constructed a Cox model in which the CAD severity index was considered as a continuous variable. The association between HRR and death was unchanged. The CAD severity index was also predictive of the risk of death (adjusted HR 1.1 for 20-point increase, 95% CI 1.0 to 1.3; p = 0.03).

Angiographic severity of CAD, HRR, and mortality in women.   There were 720 women (25%), among whom 217 (30%) had abnormal HRR and 62 (9%) had severe CAD. During follow-up, 65 died (9%). Abnormal HRR was independently predictive of death, even after accounting for age, coronary disease severity, functional capacity, ejection fraction, smoking, use of aspirin, and a history of ESRD (adjusted HR 1.5, 95% CI 1.2 to 1.9; p = 0.002). Severe angiographic CAD was also an independent predictor of death in women (adjusted HR 1.4, 95% CI 1.1 to 1.9; p = 0.01), and its strength of association was similar to that of men.

Impact of revascularization.   During the first three months after exercise testing, 435 patients (15%) underwent coronary bypass grafting and 368 (13%) underwent percutaneous revascularization. There was no association between having an abnormal HRR and undergoing subsequent bypass grafting (16% vs. 14%, p = 0.21) or percutaneous revascularization (13% vs. 12%, p = 0.33). However, severe CAD was associated with subsequent coronary artery bypass grafting (45% vs. 10%, p < 0.0001) but negatively associated with a subsequent percutaneous coronary intervention (10% vs. 13%, p = 0.04). After taking into account subsequent revascularization by adding a revascularization term into a supplementary Cox model, the association between HRR and mortality was unaffected.

Type of recovery protocol.   There were 509 patients (17%) who underwent stress echocardiography, which mandated assuming a left lateral decubitus position immediately after exercise, as opposed to the more standard upright cool-down. During follow-up, 41 (8.1%) of these patients died. Even after adjusting for age, gender, functional capacity, and angiographic severity of coronary disease, HRR was predictive of mortality among patients undergoing stress echocardiography (adjusted HR 1.9, 95% CI 1.0 to 3.5; p = 0.06), similar to patients undergoing other types of testing (adjusted HR 1.9, 95% CI 1.5 to 2.4; p < 0.0001; p = 0.98 for interaction).

Parametric analyses.   Parametric analyses confirmed an independent association of HRR with mortality, even after accounting for age, gender, left ventricular function, angiographic severity of coronary disease, functional capacity, and other possible confounders. No significant interactions were noted. Figure 2 shows how HRR was associated with predicted five-year mortality as a function of functional capacity.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 2 Association of heart rate recovery, considered as a continuous variable, with five-year predicted death rate as a function of exercise capacity. Results of parametric analyses. BPM = beats/min; METs = metabolic equivalents.

 
Previously published data.   Among the 1,551 patients on whom no HRR data have been published, 450 (29%) had abnormal HRR and 144 died during follow-up. Abnormal HRR was associated with death in unadjusted analyses (16% vs. 7%; unadjusted HR 2.5, 95% CI 1.8 to 3.4; p < 0.0001) and after adjusting for the severity of coronary disease, along with multiple other confounders (adjusted HR 1.8, 95% CI 1.3 to 2.5; p = 0.0009). There was no interaction between having been included in a previous publication and the association of HRR with death (p = 0.89 for interaction term).

Impact of beta-blockers and heart rate-lowering calcium blockers.   There were 1,614 patients (55%) who were taking neither beta-blockers nor heart rate–lowering calcium blockers. Of these, 405 (25%) had abnormal HRR; during follow-up, 170 died (11%). Abnormal HRR predicted death by itself (19% vs. 8%; unadjusted HR 2.6, 95% CI 1.9 to 3.5; p < 0.0001) and after adjustment for the severity of coronary disease and other confounders (adjusted HR 1.4, 95% CI 1.0 to 1.9; p = 0.04).

Of note, among all 2,935 patients, there was no interaction between beta-blocker use and the association of HRR with death (p = 0.34 for interaction). Similarly, there was no interaction with calcium channel blocker use (p = 0.40 for interaction). Of the 824 patients taking beta-blockers, 231 (28%) had a heart rate ≤60 beats/min at baseline. Among these patients, the risk of death associated with abnormal HRR was significant (15% vs. 8%; HR 2.1, 95% CI 1.3 to 3.5; p = 0.003). The risk of death associated with abnormal HRR did not differ among patients who had a baseline pulse >60 beats/min (19% vs. 9%; HR 2.2, 95% CI 1.0 to 4.6; p = 0.04).


    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Among patients who had exercise stress testing and who had coronary angiography within 90 days, an attenuated HRR after exercise predicted mortality. The mortality risk of abnormal HRR was comparable to having angiographically severe CAD (15,16). In fact, abnormal HRR provided additive prognostic information to the angiographic severity of CAD.

Previously, our group found that abnormal HRR predicted mortality in multiple patient groups (1–5). Only one previous study (6) has evaluated the prognostic significance of abnormal HRR once the angiographic severity of CAD is ascertained. In a male veteran population, Shetler et al. (6) found abnormal HRR to be predictive of increased mortality, independent of the angiographic severity of CAD. Attenuated HRR was not helpful in predicting the presence of significant angiographic coronary disease.

Our study confirms and extends these findings in several important respects. First, 25% of our patients were women, among whom HRR predicted death, independent of coronary disease severity, to the same extent as in men. Second, our study included patients who underwent either standard exercise stress testing with a 2-min upright cool-down period or stress echocardiography, which, per protocol, did not have an upright cool-down period. Irrespective of the testing protocol used, we found abnormal HRR to be independently predictive of death, even after accounting for the angiographic severity of coronary disease. Third, we also confirmed that HRR is a poor diagnostic test for angiographic CAD, with a sensitivity of only 31% and a specificity of 76%. Finally, our use of bootstrap resamplings and parametric analyses enabled us to deal with excessive over-optimism inherent when analyzing only one data set and to explore the importance of HRR when considered as a continuous variable.

Our study adds to growing evidence that abnormal HRR adversely affects mortality, independent of ischemic burden (1,5). The drop in heart rate after exercise is thought to represent withdrawal of the sympathetic nervous system and, more importantly, reactivation of the parasympathetic nervous system (27,28). Reduced vagal activity has been shown to adversely impact mortality in other patient populations (29,30).

At this time, additional study is needed to delineate therapeutic options for patients with abnormal HRR and to determine whether HRR is a modifiable risk factor. To date, no therapy has been systematically investigated for its ability to attenuate the risk associated with abnormal HRR. Preliminary evidence does suggest that cardiac rehabilitation improves HRR (31).

Our study was limited because it involved a single tertiary-care referral center and thus was open to biases of patient selection and referral patterns for coronary angiography. Moreover, the use of coronary angiography alone as a risk factor for future cardiac events has been called into question (32). Due to inherent problems of vessel overlap, vessel tortuosity, and vessel resolution, stenoses can be over- and/or underestimated. In addition, the degree of luminal stenoses may not correlate with the propensity for plaque rupture. Finally, our study did not identify specific causes of death, but used all-cause mortality as the end point.

We found that HRR provides additive prognostic information to the angiographic severity of coronary disease. Our findings provide further evidence supporting the routine incorporation of HRR into exercise testing interpretation.


    Footnotes
 
This study was funded by Grant HL-66004, National Heart, Lung, and Blood Institute of the National Institutes of Health, Bethesda, Maryland (Dr. Lauer, Principal Investigator).


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351–1357[Abstract/Free Full Text]
  2. Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med. 2000;132:552–555[Abstract/Free Full Text]
  3. Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation. 2001;104:1911–1916[Abstract/Free Full Text]
  4. Diaz LA, Brunken RC, Blackstone EH, Snader CE, Lauer MS. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol. 2001;37:1558–1564[Abstract/Free Full Text]
  5. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA. 2000;284:1392–1398[Abstract/Free Full Text]
  6. Shetler K, Marcus R, Froelicher VF, et al. Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol. 2001;38:1980–1987[Abstract/Free Full Text]
  7. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34:618–620[Free Full Text]
  8. Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol. 1997;30:641–648[Abstract]
  9. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154–183 (JNC-V)[CrossRef][Medline]
  10. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA. 1999;281:524–529[Abstract/Free Full Text]
  11. Lauer MS, Pashkow FJ, Snader CE, Harvey SA, Thomas JD, Marwick TH. Gender and referral for coronary angiography after treadmill thallium testing. Am J Cardiol. 1996;78:278–283[CrossRef][Medline]
  12. Lauer MS, Pashkow FJ, Harvey SA, Marwick TH, Thomas JD. Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease. J Am Coll Cardiol. 1995;26:1630–1636[Abstract]
  13. Marwick TH, Mehta R, Arheart K, Lauer MS. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83–90[Abstract]
  14. Brener SJ, Pashkow FJ, Harvey SA, Marwick TH, Thomas JD, Lauer MS. Chronotropic response to exercise predicts angiographic severity in patients with suspected or stable coronary artery disease. Am J Cardiol. 1995;76:1228–1232[CrossRef][Medline]
  15. Jones RH, Kesler K, Phillips HR 3rd, et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 1996;111:1013–1025[Abstract/Free Full Text]
  16. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation. 1994;89:2015–2025[Abstract/Free Full Text]
  17. Curb JD, Ford CE, Pressel S, Palmer M, Babcock C, Hawkins CM. Ascertainment of vital status through the National Death Index and the Social Security Administration. Am J Epidemiol. 1985;121:754–766[Abstract/Free Full Text]
  18. Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol. 1990;131:160–168[Abstract/Free Full Text]
  19. Newman TB, Brown AN. Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc. 1997;4:233–237[Abstract/Free Full Text]
  20. Cox S. Regression models and life tables. J Am Stat Soc. 1972;34:187–220
  21. Cain KC, Lange NT. Approximate case influence for the proportional hazards regression model with censored data. Biometrics. 1984;40:493–499[CrossRef][Medline]
  22. Chen CH, George SL. The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. Stat Med. 1985;4:39–46[Medline]
  23. Collett D, Stepniewska K. Some practical issues in binary data analysis. Stat Med. 1999;18:2209–2221[CrossRef][Medline]
  24. Blackstone EH, Naftel DC, Turner MEJ. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615–624[CrossRef]
  25. Nieto FJ, Coresh J. Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol. 1996;143:1059–1068[Abstract/Free Full Text]
  26. Lee J, Yoshizawa C, Wilkens L, Lee HP. Covariance adjustment of survival curves based on Cox's proportional hazards regression model. Comput Appl Biosci. 1992;8:23–27[Abstract/Free Full Text]
  27. Imai K, Sato H, Hori M, et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol. 1994;24:1529–1535[Abstract]
  28. Pierpont GL, Stolpman DR, Gornick CC. Heart rate recovery post-exercise as an index of parasympathetic activity. J Auton Nerv Syst. 2000;80:169–174[CrossRef][Medline]
  29. the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) InvestigatorsLa Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–484[CrossRef][Medline]
  30. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072–2077[Abstract/Free Full Text]
  31. Hao SC, Chai A, Kligfield P. Heart rate recovery response to symptom-limited treadmill exercise after cardiac rehabilitation in patients with coronary artery disease with and without recent events. Am J Cardiol. 2002;90:763–765[CrossRef][Medline]
  32. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333–2342[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. K. Lahiri, P. J. Kannankeril, and J. J. Goldberger
Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications.
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1725 - 1733.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L.-Y. Lin, H.-K. Kuo, L.-P. Lai, J.-L. Lin, C.-D. Tseng, and J.-J. Hwang
Inverse Correlation Between Heart Rate Recovery and Metabolic Risks in Healthy Children and Adolescents: Insight from the National Health and Nutrition Examination Survey 1999-2002
Diabetes Care, May 1, 2008; 31(5): 1015 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. W. Hughes, K. M. York, Q. Li, K. E. Freedland, R. M. Carney, and D. S. Sheps
Depressive Symptoms Predict Heart Rate Recovery After Exercise Treadmill Testing in Patients With Coronary Artery Disease: Results From the Psychophysiological Investigations of Myocardial Ischemia Study
Psychosom Med, May 1, 2008; 70(4): 456 - 460.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Arena, J. Myers, M. A. Williams, M. Gulati, P. Kligfield, G. J. Balady, E. Collins, and G. Fletcher
Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing
Circulation, July 17, 2007; 116(3): 329 - 343.
[Full Text] [PDF]


Home page
CirculationHome page
N. J. Leeper, F. E. Dewey, E. A. Ashley, M. Sandri, S. Y. Tan, D. Hadley, J. Myers, and V. Froelicher
Prognostic Value of Heart Rate Increase at Onset of Exercise Testing
Circulation, January 30, 2007; 115(4): 468 - 474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Legramante, F. Iellamo, M. Massaro, S. Sacco, and A. Galante
Effects of residential exercise training on heart rate recovery in coronary artery patients
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H510 - H515.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Kligfield and M. S. Lauer
Exercise Electrocardiogram Testing: Beyond the ST Segment
Circulation, November 7, 2006; 114(19): 2070 - 2082.
[Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
F. Giallauria, R. Lucci, M. Pietrosante, G. Gargiulo, A. De Lorenzo, M. D'Agostino, G. Gerundo, P. Abete, F. Rengo, and C. Vigorito
Exercise-based cardiac rehabilitation improves heart rate recovery in elderly patients after acute myocardial infarction.
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2006; 61(7): 713 - 717.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. B. Newman, E. M. Simonsick, B. L. Naydeck, R. M. Boudreau, S. B. Kritchevsky, M. C. Nevitt, M. Pahor, S. Satterfield, J. S. Brach, S. A. Studenski, et al.
Association of Long-Distance Corridor Walk Performance With Mortality, Cardiovascular Disease, Mobility Limitation, and Disability
JAMA, May 3, 2006; 295(17): 2018 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. De Sutter, N. Van de Veire, and I. Elegeert
Chronotropic incompetence: are the carotid arteries to blame?
Eur. Heart J., April 2, 2006; 27(8): 897 - 898.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Falcone, M. P. Buzzi, C. Klersy, and P. J. Schwartz
Rapid Heart Rate Increase at Onset of Exercise Predicts Adverse Cardiac Events in Patients With Coronary Artery Disease
Circulation, September 27, 2005; 112(13): 1959 - 1964.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. M. Bassan, I. G. Harnik, X. Jouven, J. P. Empana, and P. Ducimetiere
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
N. Engl. J. Med., August 18, 2005; 353(7): 734 - 735.
[Full Text] [PDF]


Home page
NEJMHome page
X. Jouven, J.-P. Empana, P. J. Schwartz, M. Desnos, D. Courbon, and P. Ducimetiere
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
N. Engl. J. Med., May 12, 2005; 352(19): 1951 - 1958.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Chen, E. H. Blackstone, C. E. Pothier, and M. S. Lauer
Heart Rate Recovery and Impact of Myocardial Revascularization on Long-Term Mortality
Circulation, November 2, 2004; 110(18): 2851 - 2857.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Gaibazzi
Heart rate recovery after exercise is not demonstrated as a predictor of mortality: maybe after treadmill-exercise
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 925 - 925.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vivekananthan, D. P.
Right arrow Articles by Lauer, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vivekananthan, D. P.
Right arrow Articles by Lauer, M. S.


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK